Wierda WG - Search Results

1

Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins.

Widhopf GF 2nd, Rassenti LZ, Toy TL, Gribben JG, Wierda WG, Kipps TJ. Widhopf GF 2nd, et al. Among authors: wierda wg. Blood. 2004 Oct 15;104(8):2499-504. doi: 10.1182/blood-2004-03-0818. Epub 2004 Jun 24. Blood. 2004. PMID: 15217828 Free article.

2

Chronic lymphocytic leukemia.

Wierda WG, Kipps TJ. Wierda WG, et al. Curr Opin Hematol. 1999 Jul;6(4):253-61. doi: 10.1097/00062752-199907000-00010. Curr Opin Hematol. 1999. PMID: 10400375 Review.

3

CD40 activation does not protect chronic lymphocytic leukemia B cells from apoptosis induced by cytotoxic T lymphocytes.

Chu P, Wierda WG, Kipps TJ. Chu P, et al. Among authors: wierda wg. Blood. 2000 Jun 15;95(12):3853-8. Blood. 2000. PMID: 10845920 Free article.

4

Gene therapy of hematologic malignancies.

Wierda WG, Kipps TJ. Wierda WG, et al. Semin Oncol. 2000 Oct;27(5):502-11. Semin Oncol. 2000. PMID: 11049018 Review.

5

CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia.

Wierda WG, Cantwell MJ, Woods SJ, Rassenti LZ, Prussak CE, Kipps TJ. Wierda WG, et al. Blood. 2000 Nov 1;96(9):2917-24. Blood. 2000. PMID: 11049967 Free article. Clinical Trial.

6

Immunogenetic therapy for B-cell malignancies.

Kipps TJ, Chu P, Wierda WG. Kipps TJ, et al. Among authors: wierda wg. Semin Oncol. 2000 Dec;27(6 Suppl 12):104-9. Semin Oncol. 2000. PMID: 11225994 Review.

7

T cell activation following infection of primary follicle center lymphoma B cells with adenovirus encoding CD154.

Cantwell MJ, Wierda WG, Lossos IS, Levy R, Kipps TJ. Cantwell MJ, et al. Among authors: wierda wg. Leukemia. 2001 Sep;15(9):1451-7. doi: 10.1038/sj.leu.2402208. Leukemia. 2001. PMID: 11516107

8

High expression of activation-induced cytidine deaminase (AID) and splice variants is a distinctive feature of poor-prognosis chronic lymphocytic leukemia.

McCarthy H, Wierda WG, Barron LL, Cromwell CC, Wang J, Coombes KR, Rangel R, Elenitoba-Johnson KS, Keating MJ, Abruzzo LV. McCarthy H, et al. Among authors: wierda wg. Blood. 2003 Jun 15;101(12):4903-8. doi: 10.1182/blood-2002-09-2906. Epub 2003 Feb 13. Blood. 2003. PMID: 12586616 Free article.

9

In vivo activation of signal transducer and activator of transcription 1 after CD154 gene therapy for chronic lymphocytic leukemia is associated with clinical and immunologic response.

Battle TE, Wierda WG, Rassenti LZ, Zahrieh D, Neuberg D, Kipps TJ, Frank DA. Battle TE, et al. Among authors: wierda wg. Clin Cancer Res. 2003 Jun;9(6):2166-72. Clin Cancer Res. 2003. PMID: 12796382

10

Increased expression of CD152 (CTLA-4) by normal T lymphocytes in untreated patients with B-cell chronic lymphocytic leukemia.

Motta M, Rassenti L, Shelvin BJ, Lerner S, Kipps TJ, Keating MJ, Wierda WG. Motta M, et al. Among authors: wierda wg. Leukemia. 2005 Oct;19(10):1788-93. doi: 10.1038/sj.leu.2403907. Leukemia. 2005. PMID: 16094420

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

532 results

Search Page

Filters